Xist lncRNA identified as key trigger in female-biased autoimmune diseases

Researchers uncover that the Xist ribonucleoprotein complex, unique to females, is a key driver of sex-biased autoimmunity, offering new insights into autoimmune disorders’ higher prevalence in women.

New service could cut hospital admissions for older adults and save NHS money

A new service aimed at supporting older people who are starting to become frail, could reduce emergency hospital admissions by more than a third and

February 24, 2025

Breakthrough obesity treatments on the horizon, rivaling surgery’s success

New obesity pharmacotherapies, including GLP-1 receptor agonists and combinations of entero-pancreatic hormones, show promise in achieving significant weight loss, potentially rivaling bariatric surgery’s effectiveness.

February 4, 2024

Coherus to buy Surface Oncology in stock deal valued at $65M

Coherus BioSciences is making a small stock-for-stock transaction to shore up its immuno-oncology pipeline in an acquisition of Surface Oncology that is valued at $65

June 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.